Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes. - Wikidata - awgldk - TriplyDB

Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes.

Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes.

http://www.wikidata.org/entity/Q36165605

about

Towards tumor immunodiagnostics Neoantigen-based cancer immunotherapy T-Cell-Based Immunotherapy for Osteosarcoma: Challenges and Opportunities T-cell receptor gene therapy--ready to go viral?T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer.Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole-exome sequencing.Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma.Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines.Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure).Cancer immunotherapy: Strategies for personalization and combinatorial approaches.Cancer immunotherapy targeting neoantigens.Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens.A Tumor-Specific Neo-Antigen Caused by a Frameshift Mutation in BAP1 Is a Potential Personalized Biomarker in Malignant Peritoneal Mesothelioma Stable, Nonviral Expression of Mutated Tumor Neoantigen-specific T-cell Receptors Using the Sleeping Beauty Transposon/Transposase System.Profiling cancer testis antigens in non-small-cell lung cancer.Expansion of Human Tregs from Cryopreserved Umbilical Cord Blood for GMP-Compliant Autologous Adoptive Cell Transfer Therapy.Human Leukocyte Antigen (HLA) Peptides Derived from Tumor Antigens Induced by Inhibition of DNA Methylation for Development of Drug-facilitated Immunotherapy.Vaccines targeting helper T cells for cancer immunotherapy.Autologous melanoma cell vaccine using monocyte-derived dendritic cells (NBS20/eltrapuldencel-T).Exosomes derived from tumor cells genetically modified to express Mycobacterium tuberculosis antigen: a novel vaccine for cancer therapy.T-cell receptor-engineered T cells for cancer treatment: current status and future directions.Immunogenomics: using genomics to personalize cancer immunotherapy.Antigen-specific TIL therapy for melanoma: A flexible platform for personalized cancer immunotherapy.Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients.McPAS-TCR: A manually-curated catalogue of pathology-associated T cell receptor sequences.The role of neoantigens in response to immune checkpoint blockade.Neoantigens in immunotherapy and personalized vaccines: Implications for head and neck squamous cell carcinoma.Molecular characterisation of cutaneous melanoma: creating a framework for targeted and immune therapies.Current tools for predicting cancer-specific T cell immunity.Systemic Immunity Is Required for Effective Cancer Immunotherapy.Vaccine strategies for the treatment of lymphoma: preclinical progress and clinical trial update.Immune targets and neoantigens for cancer immunotherapy and precision medicine.The Flipside of the Power of Engineered T Cells: Observed and Potential Toxicities of Genetically Modified T Cells as Therapy.'Final common pathway' of human cancer immunotherapy: targeting random somatic mutations.Adoptive T cell therapy: An overview of obstacles and opportunities.The "Achilles Heel" of Cancer and Its Implications for the Development of Novel Immunotherapeutic Strategies.MHC-multimer guided isolation of neoepitopes specific T cells as a potent-personalized cancer treatment strategy.Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy Targetless T cells in cancer immunotherapy.T cell neoepitope discovery in colorectal cancer by high throughput profiling of somatic mutations in expressed genes

P2860

Q26738691-6F4F10FB-3234-4697-8F8C-AEF084E7E758 Q26738693-5D78D56E-5DB6-41C6-BF0D-854427EC64EC Q28074619-2F21B941-7363-4EE1-A40B-A10F4B6ECC7B Q28081611-BE91AF97-BCF2-4156-9E41-FF36FDC43A1D Q30832820-4C5F5C21-85B6-4E6B-B84D-8AB532E3620E Q31148562-11A4B6EF-44CF-4F69-B9BE-CF593530A563 Q33798098-91A45AEA-7694-49C5-9FA6-A27ED7F1E0A8 Q36021163-E17700B9-F06C-44DE-8C6F-3F90261C8EDD Q36024656-54E68457-C1D8-4747-8CFA-5B7F4683C824 Q36387028-4E5A3D28-4F27-4981-BE23-F92B190F1CE2 Q36889067-400F62CA-88D4-4149-8DA0-1BD2B8ABDDC6 Q36905613-525DFD2F-7025-4548-B594-BCE5634EB8F0 Q36939300-FEF567F0-CF10-4F88-833A-7C2BBF1BD6F3 Q37043492-2B4E7A9D-D76D-4AA8-988E-26025629B0FA Q37277266-41133024-67DC-4A52-AEB5-7A5550A33B88 Q37717910-042DB13C-A4B4-463A-9E4F-77EE478CA177 Q38390185-4A779724-EE80-4AAF-925B-8F459E14F296 Q38649958-C2752806-2266-4B1D-B4FF-25FD8681B2BC Q38720221-72BD125D-F05C-4C72-A22F-578CD0BDFCE5 Q38754223-1796F026-DE76-4099-87C6-8F3F9C32F615 Q38767662-A57BC2C7-44D2-4A0B-9A77-7FE36D830104 Q38772744-F7983687-F742-4E94-9A22-DC31E108AB59 Q38784018-309625D4-2475-4538-AA50-09C17D3F99C9 Q38792012-C957206B-FC55-4832-A4CE-409C8639F8A3 Q38798110-F855BE7D-07BB-457B-A699-DFEA04894220 Q38798968-FF985197-0A4A-4824-A17F-A156501C48D1 Q38810264-02CCB116-FCA3-4B9F-A37D-302BDBD3CA0B Q38874383-F7E7A326-367E-4061-AAC5-791C2CF27DA8 Q38953021-82B5C349-7AFC-48FC-8D08-C74D04EB8032 Q39006805-C1AD3EE9-6DDA-4200-A204-F361D0775DC5 Q39043404-958FA203-3588-4B16-8167-6D724009F305 Q39057617-CE8995F4-B748-46BB-A761-9F35602D29C8 Q39115858-53A37DAD-A91E-4C76-A433-D92B1F665D52 Q39136403-700D6AE8-171C-4958-BD18-E031E9EFEBD3 Q39329596-B2CB02B3-4EBC-46E3-9C98-E157942344E4 Q39384440-D5A94102-4161-4A23-8BA8-463436F188B6 Q39397403-EBBA178A-6D03-472A-B693-FEBFF57F8999 Q39414553-DA219F5D-F77F-4B41-A07B-C2C7AB40BC50 Q40322821-E4C88372-53AD-4F37-B2A1-923176BAB620 Q40866158-D9CE1E74-9D81-4427-AEC3-C012139D9C29

P2860

Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes.

http://www.wikidata.org/entity/Q36165605

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes.

@ast

Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes.

@en

type

label

Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes.

@ast

Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes.

@en

prefLabel

Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes.

@ast

Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes.

@en

P1433

Q36165605-435A60A2-F9D6-4749-A7E7-6F32FBB64E9B

P1476

Q36165605-195DE2B2-8088-4345-A592-263EEAE46E9E

P2093

Q36165605-2884DEFF-CC07-4AB1-9875-3EBA5CC0E075

Q36165605-33FDBF90-0AB7-47E0-AA2B-1CE676C7133D

Q36165605-4079B014-7A7C-446E-8CE3-BFE012BF288D

Q36165605-4C4B31FF-AE9A-4690-A758-E5AC37C65FD2

Q36165605-599A34F1-BF07-4A7F-90CB-23973AD9BF8D

Q36165605-60BC50A1-B8B8-48AC-8E17-8625F974C64C

Q36165605-65CE1773-CF69-4CE0-AE38-72FDAFDAA25C

Q36165605-6F9E303B-5C40-4019-8FBF-046CE350B85E

Q36165605-716D96AC-A72B-428B-9441-99935A1524FB

Q36165605-87C452C4-A654-456D-8718-3C524789A911

P2860

Q36165605-05643E16-BBD6-42DB-8F96-B5AD0548F24E

Q36165605-090ECD4C-DB6A-430A-9288-F889DFF6AF2B

Q36165605-0FB03F55-9186-42B7-BB44-A3113721F302

Q36165605-138D860D-DD1C-45DC-BE3F-F90BAE4A9B8D

Q36165605-16CA61F0-44BD-4A84-B12C-269B6A1A2A16

Q36165605-1F894D0C-3A17-47F1-B424-9A8BE45D0452

Q36165605-2AADCCDB-C958-4BD8-91BE-AE97E7888CA0

Q36165605-2DF863C7-E030-4315-9737-5BDA05F64F6E

Q36165605-36DF8851-613B-48EC-976E-6E7833083206

Q36165605-447D534C-2A5F-486B-B772-C6142C9AB439

P304

Q36165605-F117FB7B-C47B-4BA8-9C64-4BC9D14BE07A

P31

Q36165605-E8A51DF2-B1F1-4D98-AEA3-6499D3ECE544

P356

Q36165605-5BDAA64E-667F-482C-B965-7353546F0EA8

P407

Q36165605-610FA91B-65F7-4A8B-9B66-712C949342F5

P433

Q36165605-4F73B306-63B1-44A3-A2BC-64E07604803F

P478

Q36165605-C3DEE2BA-24E1-47AC-B735-EAC8BB41A096

P50

Q36165605-2D86E65D-B669-485F-AEE6-915FBB50EE46

P577

Q36165605-EC5383FA-2432-464E-928C-20BB52360D4A

P698

Q36165605-2D9286C2-379B-43A9-99B9-0AA45605D784

P932

Q36165605-535EE62F-8D80-4E8A-ADA4-523E9DC0D97B

P356

P1433

Journal of Clinical Investigation

P1476

Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes.

@en

P2093

Chen Ankri

http://www.w3.org/2001/XMLSchema#string

Jared J Gartner

http://www.w3.org/2001/XMLSchema#string

Jessica S Crystal

http://www.w3.org/2001/XMLSchema#string

Kasia Trebska-McGowan

http://www.w3.org/2001/XMLSchema#string

Katerina Shamalov

http://www.w3.org/2001/XMLSchema#string

Maria R Parkhurst

http://www.w3.org/2001/XMLSchema#string

Miryam Horovitz-Fried

http://www.w3.org/2001/XMLSchema#string

Mona El-Gamil

http://www.w3.org/2001/XMLSchema#string

Paul F Robbins

http://www.w3.org/2001/XMLSchema#string

Steven A Rosenberg

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer genome landscapes

Hallmarks of Cancer: The Next Generation

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

A landscape of driver mutations in melanoma

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1

Immune Checkpoint Blockade in Cancer Therapy

Mutational landscape and significance across 12 major cancer types

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

P304

3981-3991

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI82416

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26389673

http://www.w3.org/2001/XMLSchema#string

P932

4607110

http://www.w3.org/2001/XMLSchema#string